H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

August 17, 2026 6:50 AM

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $12.00 price target on Dare Bioscience (NASDAQ: DARE).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found